Department of Medicine, University of Udine, Udine, Italy.
J Glaucoma. 2019 Sep;28(9):823-833. doi: 10.1097/IJG.0000000000001323.
The purpose of this study was to conduct a meta-analysis on the efficacy and safety of trabeculectomy (TE) and nonpenetrating glaucoma surgery (NPGS) techniques in patients with primary open-angle glaucoma, pseudoexfoliation glaucoma, pigmentary glaucoma, and normal-tension glaucoma.
All studies were identified by searching electronic sources (PubMed, Medline, Scopus, and Embase) until February 5, 2018. Primary outcome was mean intraocular pressure (IOP) reduction at 6, 12, and 24 months. Complications, number of antiglaucomatous medications, and visual outcomes were also evaluated.
Twenty-one studies were included. Ten studies compared TE with deep sclerectomy (DS), 5 with viscocanalostomy (VC), 1 study with both DS and VC, and 5 with canaloplasty (CP). TE was superior to DS, VC, and CP in reducing IOP at 6 and 12 months, and to DS at 24 months. When comparing TE to VC and to CP at 24 months, there was no significant difference in IOP reduction. Hypotony, choroidals, anterior chamber shallowing or flattening, and cataract formation or progression were more associated with TE than with NPGSs. TE was more effective in reducing antiglaucomatous medications than VC and CP.
TE is more effective in reducing IOP. TE presents a higher risk of complications as compared with NPGS, except for hyphema.
本研究旨在对原发性开角型青光眼、假性剥脱性青光眼、色素性青光眼和正常眼压性青光眼患者行小梁切除术(TE)和非穿透性青光眼手术(NPGS)的疗效和安全性进行荟萃分析。
通过检索电子资源(PubMed、Medline、Scopus 和 Embase),截至 2018 年 2 月 5 日,所有研究均被识别出来。主要结局为 6、12 和 24 个月时的平均眼内压(IOP)降低。还评估了并发症、抗青光眼药物的数量和视力结果。
共纳入 21 项研究。10 项研究比较了 TE 与深层巩膜切除术(DS),5 项研究比较了黏弹剂引流术(VC),1 项研究比较了 DS 和 VC,5 项研究比较了小梁成形术(CP)。TE 在 6 个月和 12 个月时降低 IOP 的效果优于 DS、VC 和 CP,在 24 个月时也优于 DS。在比较 TE 与 VC 和 CP 时,24 个月时的 IOP 降低没有显著差异。低眼压、脉络膜脱离或扁平、前房变浅或变平、白内障形成或进展与 TE 较 NPGS 更为相关。TE 比 VC 和 CP 更有效地减少抗青光眼药物的使用。
TE 更有效地降低 IOP。与 NPGS 相比,TE 引起并发症的风险更高,除了前房积血。